Cargando…

Comparison of the c‐MET gene amplification between primary tumor and metastatic lymph nodes in non‐small cell lung cancer

BACKGROUND: c‐MET has recently been identified as a promising novel target in non‐small cell lung cancer (NSCLC). We detected the consistency of c‐MET gene amplification in metastatic lymph nodes and tumor tissues of NSCLC patients and discuss the clinical application value of c‐MET gene amplificati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Chun‐wei, Wang, Wen‐xian, Wu, Mei‐juan, Zhu, You‐cai, Zhuang, Wu, Lin, Gen, Du, Kai‐qi, Huang, Yun‐jian, Chen, Yan‐ping, Chen, Gang, Fang, Mei‐yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582467/ https://www.ncbi.nlm.nih.gov/pubmed/28590585 http://dx.doi.org/10.1111/1759-7714.12455

Ejemplares similares

A novel co-existing ZCCHC8-ROS1 and de-novo MET amplification dual driver in advanced lung adenocarcinoma with a good response to crizotinib
por: Zhu, You-cai, et al.
Publicado: (2018)

Oncogenic EFNA4 Amplification Promotes Lung Adenocarcinoma Lymph Node Metastasis
por: Zhao, Xiangyu, et al.
Publicado: (2022)

Risk factors of non-sentinel lymph node metastasis in 443 breast cancer patients with sentinel lymph node-positive
por: Cai, Shuang-long, et al.
Publicado: (2022)

Crizotinib plus erlotinib overcomes osimertinib resistance in a seriously-ill non-small cell lung cancer patient with acquired MET amplification
por: Zhao, Zhi-Mei, et al.
Publicado: (2021)

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors
por: Peng, Lun-Xi, et al.
Publicado: (2021)

Size of Metastatic Lymph Nodes
por: Uriev, L., et al.
Publicado: (2013)

Proposal of a new nodal classification for operable non-small cell lung cancer based on the number of negative lymph nodes and the anatomical location of metastatic lymph nodes
por: Liu, Hongfeng, et al.
Publicado: (2019)

Metastatic Patterns of Mediastinal Lymph Nodes in Small-Size Non-small Cell Lung Cancer (T1b)
por: Wu, Yijun, et al.
Publicado: (2020)

Metastatic lymph nodes and prognosis assessed by the number of retrieved lymph nodes in gastric cancer
por: Wang, Hao, et al.
Publicado: (2022)

Influencing factors and clinical significance of the metastatic lymph nodes ratio in gastric adenocarcinoma
por: Yu, Ji-wei, et al.
Publicado: (2009)

Clinical implications of metastatic lymph node ratio in gastric cancer
por: Liu, Caigang, et al.
Publicado: (2007)

The Prognostic Utility of the Metastatic Lymph Node Ratio and the Number of Regional Lymph Nodes Removed from Patients with Small Bowel Adenocarcinomas
por: Aydin, Dincer, et al.
Publicado: (2023)

Patients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case report
por: Zhu, You-cai, et al.
Publicado: (2017)

Lymphography in Metastatic Lymph Node Disease
por: Burn, J. I., et al.
Publicado: (1965)

Clinical analysis of metastatic characteristics of infrapyloric lymph nodes (No.206) and terminal ileum lymph nodes in patients with right colon cancer
por: Liu, Jiangrui, et al.
Publicado: (2021)

Accurately Locating Metastatic Foci in Lymph Nodes With Lugol’s Iodine-Enhanced Micro-CT Imaging
por: Xia, Cheng-Wan, et al.
Publicado: (2021)

A case report of response to crizotinib in chemotherapy-refractory metastatic gallbladder cancer with met amplification and acquired resistance resulting from the loss of MET amplification
por: Sun, Hongna, et al.
Publicado: (2021)

Comparison of the Outcomes between Systematic Lymph Node Dissection and Lobe-Specific Lymph Node Dissection for Stage I Non-small Cell Lung Cancer
por: Huang, Ching-Chun, et al.
Publicado: (2023)

Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma
por: Zheng, Chuan-Ming, et al.
Publicado: (2018)

Genomic Landscape of Metastatic Lymph Nodes and Primary Tumors in Non-Small-Cell Lung Cancer
por: Chen, Bing, et al.
Publicado: (2022)

Integrated Ratio of Metastatic to Examined Lymph Nodes and Number of Metastatic Lymph Nodes into the AJCC Staging System for Colon Cancer
por: Gao, Peng, et al.
Publicado: (2012)

Importance of Metastatic Lymph Node Ratio in Non-Metastatic, Lymph Node-Invaded Colon Cancer: A Clinical Trial
por: Isik, Arda, et al.
Publicado: (2014)

Elucidation of inhibitory effects on metastatic sentinel lymph nodes of breast cancer during One-Step Nucleic Acid Amplification
por: Horimoto, Yoshiya, et al.
Publicado: (2018)

The Prognostic Value of Harvested Lymph Nodes and the Metastatic Lymph Node Ratio for Gastric Cancer Patients: Results of a Study of 1,101 Patients
por: Chen, Shi, et al.
Publicado: (2012)

Necessity and time interval of regional lymph node dissection for malignant melanoma with positive sentinel lymph node biopsy: Does the time interval between sentinel lymph node biopsy and completion of lymph node dissection affect outcome in malignant melanoma? A retrospective cohort study – a commentary
por: Chai, Jingxiu, et al.
Publicado: (2023)

Predictors of positive axillary lymph nodes in breast cancer patients with metastatic sentinel lymph node
por: Callejo, IP, et al.
Publicado: (2005)

Contrast-enhanced ultrasound for the differential diagnosis between benign and metastatic superficial lymph nodes: a meta-analysis
por: Mei, Mei, et al.
Publicado: (2018)

Prostate Cancer Metastatic to the Cervical Lymph Nodes
por: Sepúlveda, Luis, et al.
Publicado: (2015)

Can the Tumor Deposits Be Counted as Metastatic Lymph Nodes in the UICC TNM Staging System for Colorectal Cancer?
por: Song, Yong-Xi, et al.
Publicado: (2012)

Ultra‐small superparamagnetic iron oxides for metastatic lymph node detection: back on the block
por: Fortuin, Ansje S., et al.
Publicado: (2017)

To Identify Predictors of Central Lymph Node Metastasis in Patients with Clinically Node-Negative Conventional Papillary Thyroid Carcinoma
por: Yuan, Jiru, et al.
Publicado: (2016)

Diagnostic Value of Multimodal Magnetic Resonance Imaging in Discriminating Between Metastatic and Non-Metastatic Pelvic Lymph Nodes in Cervical Cancer
por: Xu, Jian, et al.
Publicado: (2022)

The Prognostic Impact of the Metastatic Lymph Nodes Ratio in Colorectal Cancer
por: Zhang, Chi-Hao, et al.
Publicado: (2018)

Prognostic significance of metastatic lymph node ratio: the lymph node ratio could be a prognostic indicator for patients with gastric cancer
por: Hou, Yi, et al.
Publicado: (2018)

Metastatic patterns and surgical methods for lymph nodes No. 5 and No. 6 in proximal gastric cancer
por: Wang, Jinou, et al.
Publicado: (2019)

Clonally‐related primary ALK rearranged adenocarcinoma and associated metastatic lesions
por: Zhu, You‐cai, et al.
Publicado: (2018)

Prognostic analysis of esophageal cancer in elderly patients: metastatic lymph node ratio versus 2010 AJCC classification by lymph nodes
por: Feng, Ji-Feng, et al.
Publicado: (2013)

Integration the biologic factors into the staging of breast cancer patients with ipsilateral supraclavicular lymph node metastasis
por: Lian, Chen-Lu, et al.
Publicado: (2020)

The Microanatomic Location of Metastatic Breast Cancer in Sentinel Lymph Nodes Predicts Nonsentinel Lymph Node Involvement
por: van Deurzen, Carolien H. M., et al.
Publicado: (2008)

Role of lymph node yield and lymph node ratio in predicting outcomes in non‐metastatic colorectal cancer
por: Lee, C. H. A., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_rdtmekd5kpnfdbavhb8hpatgrk